Metered Dose Inhaler Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Metered Dose Inhaler Devices Pipeline Market Overview
Metered dose inhaler devices deliver a specific amount of medication to the lungs. A metered-dose inhaler consists of a canister, a metering valve, and an actuator.
The metered dose inhaler devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
| Key Territories | · The United States
· China · The United Kingdom · Japan · South Africa |
| Key Regulatory Paths | · 510(k)
· NMPA · UKCA · CE · Ninsho |
| Leading Companies | · Aerophase Inc
· Bloom Labs · DMK Pharmaceuticals Corp · GSK plc · Impulse Biomedical |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Buy the Full Report for More Insights into the Metered Dose Inhaler Devices Pipeline Market
Metered Dose Inhaler Devices Pipeline Market Segmentation by Territories
The United States (US), China, The United Kingdom, Japan, and South Africa among others are a few of the key territories of the metered dose inhaler devices pipeline market. As of July 2024, the US accounted for the highest number of pipeline products.
Metered Dose Inhaler Devices Pipeline Market Analysis by Territories, 2024 (%)
Buy the Full Report for More Territory Insights into the Metered Dose Inhaler Devices Pipeline Market
Metered Dose Inhaler Devices Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths in the metered dose inhaler devices pipeline products market are 510(k), NMPA, UKCA, CE, and Ninsho. As of July 2024, 510(k) was the most followed pathway for pipeline products in the metered dose inhaler devices market.
Metered Dose Inhaler Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)
Buy the Full Report for More Regulatory Path Insights into the Metered Dose Inhaler Devices Pipeline Market
Metered Dose Inhaler Devices Pipeline Market – Competitive Landscape
A few of the key companies associated with the metered dose inhaler devices pipeline market are Aerophase Inc, Bloom Labs, DMK Pharmaceuticals Corp, GSK plc, and Impulse Biomedical, among others.
Aerophase Inc: Aerophase is headquartered in Longmont, Colorado, the US. Aerophase Inc (Aerophase) develops pharmaceutical products to treat lung cancer. The company is investigating its lead product candidate Pulmitaxel, a proprietary aerosol formulation of paclitaxel for the treatment of non-small cell lung cancer. Aerophase’s patented technology enables the delivery of lipophilic anticancer agents into the lungs. It seeks to work in partnership with pharmaceutical companies and equity investors to develop its products.
GSK plc: GSK plc (GSK) is a healthcare company that focuses on developing, manufacturing and commercializing general medicines, specialty medicines and vaccines. It offers drugs for the treatment of diseases such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, urogenital, anti-bacterial, dermatology, and rare diseases.
Metered Dose Inhaler Devices Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Metered Dose Inhaler Devices Pipeline Market
Download a Free Report Sample
Segments Covered in the Report
Metered Dose Inhaler Devices Pipeline Market Territories Outlook (2024)
- The United States
- China
- The United Kingdom
- Japan
- South Africa
Metered Dose Inhaler Devices Pipeline Market Regulatory Paths Outlook (2024)
- 510(k)
- NMPA
- UKCA
- CE
- Ninsho
Scope
This report provides:
- Extensive coverage of the metered dose inhaler devices under development.
- Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of metered dose inhaler devices and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of metered dose inhaler devices under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Bloom Labs
DMK Pharmaceuticals Corp
Globe Medical Tech Inc (Inactive)
GSK plc
Impulse Biomedical
Kindeva Drug Delivery LP
Lab Automate Technologies Inc
Lupin Pharmaceuticals Inc
Medicom Innovation Partner a/s
Nemera La Verpilliere
Niox Group Plc
Pearl Therapeutics Inc
Rapid Therapeutic Science Laboratories Inc
Reciprocal Labs Corp
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Syqe Medical Ltd
TM Global Bioscience LLC
Transpire Bio Inc
Verona Pharma Plc
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the metered dose inhaler devices pipeline market as of July 2024?
As of July 2024, the US accounted for the highest number of pipeline products in the metered dose inhaler devices market.
-
Which was the most followed regulatory pathway in the metered dose inhaler devices pipeline market as of July 2024?
As of July 2024, 510(k) was the most followed pathway for pipeline products in the metered dose inhaler devices market.
-
Which are the major companies operating in the metered dose inhaler devices pipeline market?
A few of the key companies associated with the metered dose inhaler devices pipeline market are Aerophase Inc, Bloom Labs, DMK Pharmaceuticals Corp, GSK plc, and Impulse Biomedical, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Sample Report
Metered Dose Inhaler Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Metered Dose Inhaler Devices reports
